Literature DB >> 9876217

Emerging roles for proteinases in cancer.

A Noël1, C Gilles, K Bajou, L Devy, F Kebers, J M Lewalle, E Maquoi, C Munaut, A Remacle, J M Foidart.   

Abstract

Metalloproteinases and serine proteinases have been associated with tumor invasion and formation of metastasis which represent the major obstacles to cancer cure. The contribution of proteinases in these processes was initially thought to be the destruction of extracellular matrices. However, recent evidence suggests that they mainly affect tumor growth rather than invasion. Proteinases can indeed generate active matrix protein fragments, influence the release, the activation and the bioavailability of growth factors, and consequently modulate tumor cell growth, apoptosis and angiogenesis. Additionally, proteinases, their receptors and/or inhibitors can be directly involved in cell migration and in the processing or shedding of cell surface proteins. Further elucidation of the functions of proteinases is essential for the development of novel anticancer strategies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9876217

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  21 in total

1.  Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis.

Authors:  Karim Si-Tayeb; Arnaud Monvoisin; Claire Mazzocco; Sébastien Lepreux; Marion Decossas; Gaëlle Cubel; Danièle Taras; Jean-Frédéric Blanc; Derrick R Robinson; Jean Rosenbaum
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

2.  Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration.

Authors:  Elisabeth L Bair; Man Ling Chen; Kathy McDaniel; Kiyotoshi Sekiguchi; Anne E Cress; Raymond B Nagle; George Timothy Bowden
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

3.  Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.

Authors:  Manisha Tripathi; Alka A Potdar; Hironobu Yamashita; Brandy Weidow; Peter T Cummings; Daniel Kirchhofer; Vito Quaranta
Journal:  Prostate       Date:  2011-02-01       Impact factor: 4.104

4.  Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells.

Authors:  Ebony Hoskins; Jaime Rodriguez-Canales; Stephen M Hewitt; Wafic Elmasri; Jasmine Han; Shing Han; Ben Davidson; Elise C Kohn
Journal:  Gynecol Oncol       Date:  2011-06-14       Impact factor: 5.482

5.  MiR-338-5p Promotes Glioma Cell Invasion by Regulating TSHZ3 and MMP2.

Authors:  Yanyan Li; Yulun Huang; Zhenyu Qi; Ting Sun; Youxin Zhou
Journal:  Cell Mol Neurobiol       Date:  2017-08-05       Impact factor: 5.046

6.  Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables.

Authors:  Yi-Hong Zhou; Kenneth R Hess; Longjian Liu; Mark E Linskey; W K Alfred Yung
Journal:  Neuro Oncol       Date:  2005-10       Impact factor: 12.300

Review 7.  Heme oxygenase-1 in tumors: is it a false friend?

Authors:  Alicja Jozkowicz; Halina Was; Jozef Dulak
Journal:  Antioxid Redox Signal       Date:  2007-12       Impact factor: 8.401

8.  Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells.

Authors:  Igor Bryukhovetskiy; Valeriy Shevchenko
Journal:  Oncol Lett       Date:  2016-06-22       Impact factor: 2.967

9.  Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model.

Authors:  Srinivas Nandana; Katharine Ellwood-Yen; Charles Sawyers; Marcia Wills; Brandy Weidow; Thomas Case; Valeri Vasioukhin; Robert Matusik
Journal:  Prostate       Date:  2010-05-01       Impact factor: 4.104

10.  Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression.

Authors:  Manisha Tripathi; Srinivas Nandana; Hironobu Yamashita; Rajkumar Ganesan; Daniel Kirchhofer; Vito Quaranta
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.